4//SEC Filing
Karpf David B 4
Accession 0001126234-22-000101
CIK 0001126234other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:55 PM ET
Size
5.8 KB
Accession
0001126234-22-000101
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Karpf David B
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2022-09-01$8.53/sh−570$4,862→ 7,330 total
Footnotes (3)
- [F1]Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 1,875 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
- [F2]Includes 400 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F3]Includes 5,625 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on September 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001622067
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 4:55 PM ET
- Size
- 5.8 KB